Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac(®)) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents.
- DOI
- 10.3390/vaccines12080938
- Published
- 2024 Aug 22
- Container
- Vaccines
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines12080938,
title = {Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac(®)) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents.},
author = {Fadlyana E and Rusmil K and Dwi Putra MG and Fulendry FP and Somantri NK and Putri AD and Sari RM and Puspita M and Dewi GP},
year = {2024},
journal = {Vaccines},
doi = {10.3390/vaccines12080938},
url = {https://doi.org/10.3390/vaccines12080938}
}RIS
TY - JOUR TI - Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac(®)) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents. AU - Fadlyana E AU - Rusmil K AU - Dwi Putra MG AU - Fulendry FP AU - Somantri NK AU - Putri AD AU - Sari RM AU - Puspita M AU - Dewi GP PY - 2024 JO - Vaccines DO - 10.3390/vaccines12080938 UR - https://doi.org/10.3390/vaccines12080938 ER -
APA
E, F., K, R., MG, D. P., FP, F., NK, S., AD, P., RM, S., M, P., & GP, D. (2024). Immunogenicity and Safety of SARS-CoV-2 Protein Subunit Recombinant Vaccine (IndoVac(®)) as a Heterologous Booster Dose against COVID-19 in Indonesian Adolescents.. Vaccines. https://doi.org/10.3390/vaccines12080938
Source records
- pubmed · retrieved 2026-09-26T06:08:16.013Z
- europe-pmc · retrieved 2026-09-26T06:08:16.022Z
- doaj · retrieved 2026-09-26T06:08:15.996Z